New Quit Smoking Pill is Worth Trying!

User Rating:  / 0
The new quit smoking pill as it sounds to be is not a revolution in the field of quit smoking aids available but another step ahead for those who have not been successful in quitting with the already available products.

Varenicline (Chantix) which has got approval for use in 2006 by the Food and Drug Administration is the second nicotine free smoking cessation drug to get this kind of approval. Chantix works in such a way that it blocks the nicotine receptors in the brain. Dopamine is released in the pleasure centre of the brain when nicotine is taken which is the main cause of harm to the body. Chantix reduces the release of dopamine by simply blocking the nicotine receptors in the brain, thereby reducing the need to smoke and also relaxes the pain associated with the withdrawal symptoms.

The course is mainly of 12 weeks to start with which can be doubled later depending on the need and level of the smoker. This new quit smoking pill can be started off one week with a dose of one pill daily before a person fixes his quit date, then can be increased to 2 pills which can be gradually increased in order to observe lesser side effects. It is recommended not to use Chantix with other smoking cessation products. It is not that it is free from side effects such as nausea, vomiting, gas, headache, insomnia but is lesser in comparison to other brands available known as Zyban. Chantix has observed a success rate of 22% as compared to 16% of Zyban.

This new quit smoking pill has made many achievements on its way as the smokers who were not able to quit smoking with the help of Zyban were successful with the use of Chantix. May be this has been said to promote the product but giving it a try would be worth enough as the main thing which helps a person to quit smoking is his own will power, dedication and loyalty with which he uses a product to get the result. But before going for any product, doctor?s advice is recommended at every step.